BSG and benign neoplasm: All 3 MCT isoforms, as well as the chaperone CD147, were expressed at high frequency in the plasma membrane of most tumor samples (around 60-90%) and, for MCT4, the frequency of expression was higher in malignant than in benign tumors, however, with no statistical significance.